Goldline Pharmaceutical Ltd. sells their branded pharmaceutical goods and operates in the marketing and distribution sectors. The company offers several products along different therapeutic segments and caters to doctors, specialists, surgeons, pediatricians, cardiologists as well as critical care consultants. The company uses an asset-light business model. They partner with th
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 9,84,000 crores |
| Non-Institutional Investors (NIIs) | 15% | 2,95,200 crores |
| Retail Individual Investors (RIIs) | 35% | 6,88,800 crores |
Management comprised of experienced promoters
Asset-light and scalable business model
Wide range of diverse pharmaceutical products
Strong linkages to suppliers and vendors
Distribution and marketing structures already in place
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 15 May '26 | -- | 18 May '26 |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 19,68,000 shares (aggregating up to ₹2,58,000 crores) |
| Fresh Issue | 2,56,200 shares (aggregating up to ₹25,62,000 crores) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Book building |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 79.7 shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Goldline Pharmaceutical ipo has been designed to ensure broad participation while maintaining optimal price discovery.
103 F-1 Leela Apartment Shilpa Hsg Society Nagpur
Bigshare Services Pvt.Ltd.
| Book Running Lead Manager(s) |
|---|
| Cumulative Capital Pvt Ltd |